在心房的急性中风的管理和预后
Mette F Hindsholm1,2, Dorte Damgaard1, M Edip Gurol3,4
1Department of Neurology, Aarhus University Hospital, 8200 Aarhus, Denmark.
Journal of clinical medicine
|September 9, 2023
概括
心房动 (AF) 增加了中风的风险. 管理AF相关的中风需要平衡抗凝效益与出血风险,以获得最佳的患者结果.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心房动 (AF) 是缺血性中风 (IS) 的重要危险因素.
- 口服抗凝药 (OAC) 降低了IS风险,但增加了出血,包括脑内出血 (ICH).
- 与AF相关的中风比非AF中风带来更高的残疾和死亡率.
研究的目的:
- 审查AF患者缺血性和出血性中风的急性管理.
- 讨论急性和长期管理策略的预后和影响.
主要方法:
- 对AF患者中风管理当前知识的文献综述.
- 对AF的OAC风险效益分析数据的综合分析.
主要成果:
- 与AF相关的中风带来了独特的管理挑战.
- 平衡抗凝治疗对于治疗中风的AF患者至关重要.
- 了解预后是有效治疗策略的关键.
结论:
- 有效管理AF相关的中风需要仔细考虑个体患者的风险和益处.
- 优化急性和长期策略对于改善AF中风患者的结果至关重要.
相关概念视频
Atherosclerosis IV: Nursing Management
21
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
21
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12


